Literature DB >> 1393775

Risk for developing osteoporosis in untreated premature menopause.

A C Bagur1, C A Mautalen.   

Abstract

The bone mineral density (BMD) of the lumbar spine and proximal femur was determined by dual photon absorptiometry in 32 women with untreated premature menopause (cessation of menses before 45 years of age). The BMD of the spine and proximal femur in four obese patients was not different from the BMD of the age-matched controls. On the contrary, the BMD of the nonobese females with premature menopause was significantly lower with respect to the average values found in healthy young women, in age-matched and menopause-matched controls. The BMD deficit was greater over the lumbar spine than in the proximal femur. Forty three percent of nonobese patients were already under the vertebral fracture threshold and 25% of nonobese patients were below the hip fracture threshold. The BMD deficit in the lumbar spine was correlated to the loss observed in the femoral neck (r = 0.59, P less than 0.001), in the trochanter (r = 0.65, P less than 0.001) and in the Ward's triangle (r = 0.73, P less than 0.001). A negative correlation was observed between years of menopause and the BMD of the lumbar spine (r = -0.39, P less than 0.05). The results indicate the high individual risk for osteoporotic fractures in nonobese females with untreated premature menopause. The BMD loss was greater over the skeletal areas that are predominantly composed of trabecular bone compared with cortical bone.

Entities:  

Mesh:

Year:  1992        PMID: 1393775     DOI: 10.1007/bf00296207

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  26 in total

1.  The effect of age and menopause on bone mineral density of the proximal femur.

Authors:  L R Hedlund; J C Gallagher
Journal:  J Bone Miner Res       Date:  1989-08       Impact factor: 6.741

2.  Obesity and postmenopausal bone loss: the influence of obesity on vertebral density and bone turnover in postmenopausal women.

Authors:  C Ribot; F Tremollieres; J M Pouilles; M Bonneu; F Germain; J P Louvet
Journal:  Bone       Date:  1987       Impact factor: 4.398

3.  Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women.

Authors:  W H Matta; R W Shaw; R Hesp; R Evans
Journal:  Clin Endocrinol (Oxf)       Date:  1988-07       Impact factor: 3.478

4.  Age-related bone loss in women evaluated by the single and dual photon technique.

Authors:  L Nilas; A Gotfredsen; A Hadberg; C Christiansen
Journal:  Bone Miner       Date:  1988-04

5.  The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism.

Authors:  J S Johansen; B J Riis; C Hassager; M Moen; J Jacobson; C Christiansen
Journal:  J Clin Endocrinol Metab       Date:  1988-10       Impact factor: 5.958

6.  Relative contributions of aging and estrogen deficiency to postmenopausal bone loss.

Authors:  L S Richelson; H W Wahner; L J Melton; B L Riggs
Journal:  N Engl J Med       Date:  1984-11-15       Impact factor: 91.245

7.  A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis.

Authors:  J C Stevenson; B Lees; R Gardner; R W Shaw
Journal:  Horm Res       Date:  1989

8.  Bone mass and its relationship to age and the menopause.

Authors:  L Nilas; C Christiansen
Journal:  J Clin Endocrinol Metab       Date:  1987-10       Impact factor: 5.958

9.  Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.

Authors:  D P Kiel; D T Felson; J J Anderson; P W Wilson; M A Moskowitz
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

10.  Effect of early menopause on bone mass in normal women and patients with osteoporosis.

Authors:  E Seeman; M E Cooper; J L Hopper; E Parkinson; J McKay; G Jerums
Journal:  Am J Med       Date:  1988-08       Impact factor: 4.965

View more
  18 in total

1.  Estrogen receptor alpha overexpressing mouse antral follicles are sensitive to atresia induced by methoxychlor and its metabolites.

Authors:  Tessie Paulose; Patrick R Hannon; Jackye Peretz; Zelieann R Craig; Jodi A Flaws
Journal:  Reprod Toxicol       Date:  2012-01-28       Impact factor: 3.143

2.  Mono(2-ethylhexyl) phthalate accelerates early folliculogenesis and inhibits steroidogenesis in cultured mouse whole ovaries and antral follicles.

Authors:  Patrick R Hannon; Katherine E Brannick; Wei Wang; Jodi A Flaws
Journal:  Biol Reprod       Date:  2015-03-25       Impact factor: 4.285

3.  Co-treatment of mouse antral follicles with 17β-estradiol interferes with mono-2-ethylhexyl phthalate (MEHP)-induced atresia and altered apoptosis gene expression.

Authors:  Zelieann R Craig; Jeffrey Singh; Rupesh K Gupta; Jodi A Flaws
Journal:  Reprod Toxicol       Date:  2014-01-09       Impact factor: 3.143

4.  Different rates of forearm bone loss in healthy women with early or late menopause.

Authors:  G Luisetto; M Zangari; F Bottega; F Peccolo; P Galuppo; A Nardi; D Ziliotto
Journal:  Osteoporos Int       Date:  1995-01       Impact factor: 4.507

5.  Equol inhibits growth, induces atresia, and inhibits steroidogenesis of mouse antral follicles in vitro.

Authors:  Sharada Mahalingam; Liying Gao; Marni Gonnering; William Helferich; Jodi A Flaws
Journal:  Toxicol Appl Pharmacol       Date:  2016-02-11       Impact factor: 4.219

6.  Osteoporosis and years since menopause.

Authors:  S Ide; Y Hirota; T Hotokebuchi; S Takasugi; Y Sugioka; H Hayabuchi
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

7.  Short term exposure to di-n-butyl phthalate (DBP) disrupts ovarian function in young CD-1 mice.

Authors:  Nivedita Sen; Xiaosong Liu; Zelieann R Craig
Journal:  Reprod Toxicol       Date:  2015-03-09       Impact factor: 3.143

8.  Di-n-butyl phthalate disrupts the expression of genes involved in cell cycle and apoptotic pathways in mouse ovarian antral follicles.

Authors:  Zelieann R Craig; Patrick R Hannon; Wei Wang; Ayelet Ziv-Gal; Jodi A Flaws
Journal:  Biol Reprod       Date:  2013-01-31       Impact factor: 4.285

9.  Bisphenol A down-regulates rate-limiting Cyp11a1 to acutely inhibit steroidogenesis in cultured mouse antral follicles.

Authors:  Jackye Peretz; Jodi A Flaws
Journal:  Toxicol Appl Pharmacol       Date:  2013-05-22       Impact factor: 4.219

10.  Genistein exposure inhibits growth and alters steroidogenesis in adult mouse antral follicles.

Authors:  Shreya Patel; Jackye Peretz; Yuan-Xiang Pan; William G Helferich; Jodi A Flaws
Journal:  Toxicol Appl Pharmacol       Date:  2016-01-12       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.